10-K: US Nuclear Corp. Reports Reduced Annual Loss Amidst Going Concern Doubts and Internal Control Deficiencies

US Nuclear Corp. (UCLE) reported a significant reduction in its net loss for fiscal year 2024, driven by improved gross margins and lower other expenses, despite facing substantial doubt about its ability to continue as a going concern and acknowledging ineffective internal controls.

Summary

• US Nuclear Corp. (UCLE) reported a net loss of $1,739,926 for the fiscal year ended December 31, 2024, a 49.3% improvement from the $3,433,804 net loss in 2023.
• Revenue slightly decreased by 1.8% to $2,190,398 in 2024 from $2,231,095 in 2023, attributed by management to slowed growth due to political and economic uncertainties.
• Gross profit increased by 9.9% to $1,015,629 in 2024 from $924,306 in 2023, with gross margin improving to 46.37% from 41.43%.
• Other expenses saw a substantial decrease of 88.6%, falling to $204,773 in 2024 from $1,792,160 in 2023, primarily due to reductions in interest expense and debt discounts.
• The company has an accumulated deficit of $19,676,325 as of December 31, 2024, and its ability to continue as a going concern is in substantial doubt.
• Management plans to raise an additional $5 million in capital over the next twelve months through private placement offerings of debt and equity securities.
• The company's disclosure controls and procedures, as well as internal controls over financial reporting, were deemed ineffective as of December 31, 2024, citing lack of proper segregation of duties, no formal documentation, and insufficient supervision.
• International revenues accounted for 23.82% of total revenue in 2024, an increase of 12.39% from 2023, with South Korea and China expected to be major contributors to future growth.
• The Overhoff Technology division generated 50.49% of total revenues in 2024 from just four customers, indicating high customer concentration.
• The company authorized up to 8,122 shares of Series A Convertible Preferred Stock at $1,000 per share, with existing management beneficially owning 1,878 shares from loan conversions.
• Series A Preferred Stock holders are entitled to an annual dividend of 6% cash on stated value and 1,200 shares of common stock per preferred share, with each preferred share equating to 10,000 common shares for voting purposes.
• As of December 31, 2024, 2,006 shares of Series A preferred stock were outstanding, with 1,878 shares obligated for issuance to related parties for debt conversion and 128 shares for cash.

Sentiment

Score: 4

Explanation: While the company significantly reduced its net loss and improved gross margins, these positives are heavily outweighed by the 'going concern' warning, acknowledged ineffective internal controls, and the stated need for a substantial capital raise, indicating significant underlying financial and operational instability.

Positives

• Net loss significantly reduced by 49.3% in 2024 to $1,739,926 from $3,433,804 in 2023.
• Gross profit increased by 9.9% to $1,015,629 in 2024, and gross margin improved to 46.37% from 41.43%.
• Other expenses decreased substantially by 88.6% to $204,773, primarily due to lower interest expense and debt discounts.
• Total liabilities decreased by 27.62% to $3,503,012 in 2024 from $4,839,495 in 2023.
• Shareholders' equity improved (less negative) to $(856,165) in 2024 from $(1,982,619) in 2023.
• International revenue increased by 12.39% in 2024, indicating growing global market penetration.
• The company holds a leading market share in Tritium monitors through its Overhoff Technology Corp unit.
• Proprietary technology and high barriers to entry are cited as defensible aspects of the business.
• Partnership with FlyCam UAV for DroneRAD Aerial Radiation Detection expands product offerings.
• CEO Robert I. Goldstein possesses over 40 years of experience in nuclear radiation detection, with product approvals from EPA, FDA, and NRC.

Negatives

• The company has an accumulated deficit of $19,676,325 and reported net losses, raising substantial doubt about its ability to continue as a going concern.
• Revenue slightly decreased by 1.8% in 2024, indicating slowed growth.
• Cash used in operating activities increased to $509,053 in 2024 from $263,444 in 2023, indicating increased cash burn.
• Cash balance decreased to $130,840 in 2024 from $152,840 in 2023.
• Disclosure controls and procedures were deemed ineffective as of December 31, 2024.
• Internal controls over financial reporting were deemed ineffective due to lack of proper segregation of duties, no formal documentation, and insufficient supervision.
• The company is highly dependent on international customers for future growth, which is subject to unpredictable factors.
• A significant portion of revenue (50.49% in 2024) comes from the Overhoff Technology division, with high customer concentration (four customers).
• The company operates in a highly competitive industry against larger competitors with greater resources.
• Reliance on the continued acceptance of nuclear technology, which is vulnerable to safety concerns and public resistance.
• The company does not hold current patents on most products, relying on trade secrets and proprietary know-how, which may be difficult to protect.
• The company needs to raise an additional $5 million over the next twelve months to fund business plans.
• Future equity or convertible debt issuances could dilute existing shareholder interests.
• The company's common stock is subject to price volatility and penny stock considerations.
• No cash dividends are expected to be paid for the foreseeable future.
• Management and affiliates hold significant control (approximately 37.3%) of the common stock, potentially conflicting with other stockholders' interests.
• The company does not have standing Audit, Compensation, or Nominating and Corporate Governance Committees, nor an audit committee financial expert.
• The company has not adopted a formal written code of ethics.
• The company was in default on a note payable as of December 31, 2024.
• Accrued unpaid salary for the CEO, Robert I. Goldstein, was $13,000 as of December 31, 2024.

Risks

• The business is intensely competitive, and revenues are unpredictable due to competition from larger companies with greater resources and capabilities.
• The market for nuclear radiation safety equipment is dependent upon factors beyond the company's control, including pricing, new entrants, newer technologies, market regulation, government policy, and fossil fuel energy prices.
• Heavy reliance on international customers for business (23.82% of total revenue in 2024) exposes the company to foreign market uncertainties.
• Government regulation, particularly by the Nuclear Regulatory Commission (NRC) and foreign government policies, can adversely affect the business.
• Opponents to nuclear energy and safety concerns (e.g., Fukushima Daiichi incident) could lead to decreased public acceptance and demand for nuclear technology and related equipment.
• Continued growth and orders from CANDU, Molten Salt Reactors (MSR), and Liquid-Fluoride Thorium Reactors (LFTR) are crucial for tritium-based equipment sales, and failure to develop these markets could adversely affect profitability.
• Failure to make accretive acquisitions and successfully integrate them could adversely affect future financial results, leading to unforeseen operating difficulties and expenditures.
• The company relies primarily on trade secrets, copyright, and trademark laws to protect its technology, with no current patents on products (only a provisional patent for tritium products), making intellectual property difficult to protect and susceptible to infringement.
• The company's failure to obtain additional capital (anticipated $5 million over the next twelve months) may significantly restrict proposed operations.
• The company is subject to the risk that certain key personnel, including CEO Robert I. Goldstein and CFO Michael Hastings, will cease to be involved, adversely affecting financial condition and operations.
• Competition from other radiation detection or related companies could decrease business and financial performance.
• Regulations like Sarbanes-Oxley Act (SOX) and Dodd-Frank Act increase the cost of doing business and may make it difficult to attract or retain qualified officers and directors.
• Limitations on director and officer liability and indemnification may discourage stockholders from bringing suit against a director.
• Future acquisitions involve risks such as difficulties in assimilation, diversion of management attention, inability to maximize financial position, additional expenses, and impairment of existing relationships.
• Failure to attract and retain skilled technical, sales, marketing, and operational employees could harm the business.
• Failure to manage growth effectively could harm the ability to attract and retain key personnel and adversely impact operating results.
• If the company raises additional funds by issuing equity or convertible debt securities, existing shareholder interests may be diluted.
• The company's stock price may be volatile or decline regardless of operating performance due to various market and industry factors.
• The common stock is subject to risks arising from restrictions on reliance on Rule 144 by shell companies or former shell companies, as the company was formerly a shell company.
• If securities or industry analysts do not publish research or publish inaccurate or unfavorable research, the stock price and trading volume could decline.
• Management and other affiliates have significant control (approximately 37.3%) of the common stock, potentially controlling actions in a manner that conflicts with other stockholders' interests.
• The company's shares likely will be 'penny stocks' (less than $5.00), subjecting them to special sales practice and disclosure requirements for broker-dealers.
• Failure to achieve and maintain effective internal controls in accordance with Section 404 of SOX could have a material adverse effect on business and operating results, and lead to loss of investor confidence.
• The company does not expect to pay any cash dividends for the foreseeable future, as surplus income is planned for reinvestment.
• Cybersecurity threats pose an ongoing concern, and future incidents could materially adversely affect the business, results of operations, and financial condition.

Future Outlook

US Nuclear Corp. anticipates that a significant portion of its future sales and business strategy will be tied to the growth of next-generation nuclear reactors like Molten Salt Reactors (MSR) and Liquid-Fluoride Thorium Reactors (LFTR), as well as continued orders from CANDU reactors. The company expects its international business, particularly in South Korea and China, to become a larger component of revenue as clean energy nuclear technology develops abroad. Management plans to seek an additional capital raise of $5 million over the next twelve months to fund business plans and intends to reinvest any future surplus income into company growth. The company also plans to establish an Audit Committee, Compensation Committee, and Nominating and Corporate Governance Committee, and adopt a formal written code of conduct in the future.

Management Comments

• "The decrease of $40,697 or 1.8% [in revenue] is considered by management to be indicative of slowed growth due to political and economic uncertainties."
• "We believe that South Korea, Japan and Australia in the Southeast Asian region, and France, Germany and other countries in Eastern and Western Europe, should be major contributors to our growth in revenues over the next few years."
• "The Company expects that a significant portion of its future sales and business strategy is tied to the growth of MSR and LFTRs, as well as from CANDU reactors."
• "Management has plans to seek additional capital through some private placement offerings of debt and equity securities. These plans, if successful, will mitigate the factors which raise substantial doubt about the Companys ability to continue as a going concern."
• "It is managements intention to acquire other businesses to grow our customer base, to expand into new markets, and to provide new product lines."
• "We will focus on diversifying our product line into a larger range so that our customers and vendors may have a more expansive experience in type, choice, options, price and selection. We also believe that with a more diverse product line we will become more competitive as our industry is intensely competitive."
• "While efforts are being made to enhance our internal metrics and reporting processes, currently, a complete suite of expense metrics for evaluating the effectiveness of our resource allocation across all segments is not fully operational."

Industry Context

The nuclear power industry is undergoing a transformation with the emergence of new technologies such as Small Modular Reactors (SMR), Molten Salt Reactors (MSR), and Liquid-Fluoride Thorium Reactors (LFTR), which are expected to drive future growth in nuclear power generation. Nuclear energy is increasingly viewed as a 'green and clean' source due to its zero carbon emissions. Globally, 32 countries operate 436 nuclear reactors, with 57 new reactors under construction in 11 countries as of May 2023, indicating continued expansion. The U.S. has 93 nuclear power plants contributing 19% of its total electricity. Research into nuclear fusion power, with 124 active laboratories in 2023, is also creating a growing market for tritium detection equipment. However, the industry faces significant opposition due to safety concerns, with past incidents like Fukushima leading to nuclear phase-outs in countries like Germany, Switzerland, and Italy. US Nuclear Corp. operates in a highly competitive landscape, competing with larger, more resourced companies such as Thermo Fisher Scientific, Canberra Industries, Mirion Technologies, Ludlum Measurements, Smiths Detection, and Lab Impex Systems Ltd.

Comparison to Industry Standards

• US Nuclear Corp. states it has a 'reasonable edge against competitors' and 'limited competition in the water monitor business' due to over ten years of investment in developing highly sensitive detectors, implying a competitive advantage in this niche.
• The company claims its Overhoff Technology unit has 'leading control over market share in the Tritium monitor space as the top maker of Tritium monitors,' suggesting a dominant position in this specialized segment.
• US Nuclear Corp. asserts that 'only US Nuclear Corp offers these full-service monitors' for combating tritium and C-14 pollution nuclides from nuclear power plants, indicating a unique product offering compared to competitors.
• The document highlights that competitors like Thermo Fisher Scientific, Canberra Industries, Mirion Technologies, Ludlum Measurements, Smiths Detection, and Lab Impex Systems Ltd. have 'larger customer bases, greater brand recognition and significantly greater financial, marketing, personnel, technical and other resources,' implying US Nuclear Corp. operates at a disadvantage in terms of scale and resources compared to these industry giants.
• No specific numerical benchmarks or comparable company financial results (e.g., revenue per employee, R&D spend as % of revenue, specific project success rates) are provided for a detailed quantitative comparison against industry standards or specific competitors.

Management Changes

Corporate Governance

Related Party Transactions

• The company leases its facilities in Canoga Park, CA, and Milford, Ohio, from Gold Team Inc., a company principally owned by CEO Robert I. Goldstein. Rent expense was $162,000 in 2024 and $176,000 in 2023.
• As of September 30, 2024, Gold Team Inc. converted $300,000 of accrued rent payable to a long-term note payable and $300,000 to Series A Convertible Preferred shares.
• CEO Robert I. Goldstein loaned the company a net of $375,233 during 2024 ($531,100 loaned, $155,868 repaid).
• As of September 30, 2024, CEO Robert I. Goldstein converted $350,000 of his accrued salary into a note payable and $375,000 into Series A Convertible Preferred stock.
• As of December 31, 2024, the company had $13,000 in accrued compensation payable to its CEO.
• On March 3, 2023, the company divested its wholly-owned subsidiary, Cali From Above, to CEO Robert Goldstein.
• During 2024, former CFO Richard Landry forgave $60,000 of accrued compensation owed to him and converted the remaining $150,000 balance to a note payable.
• During 2024, CFO Michael Hastings invested an aggregate of $200,000, comprising a $72,000 convertible promissory note and $128,000 for Series A Preferred shares.
• CFO Michael Hastings provided short-term notes payable to the company: $9,000 on March 26, 2025, $21,000 on April 2, 2025, and $25,000 on June 10, 2025.

Stakeholder Impact

• **Shareholders**: Face potential dilution from future capital raises, stock price volatility due to penny stock status, and no expected cash dividends. The significant control by management (37.3%) may limit influence of other shareholders. Ineffective internal controls and a going concern warning pose substantial risks to investment value.
• **Employees**: The company's dependence on key personnel, including the CEO and CFO, means their retention is critical for business continuity. The lack of a formal retirement plan may affect employee benefits and retention.
• **Customers**: The company's strategy to diversify its product line and customer base aims to provide a more expansive experience and increase competitiveness, potentially benefiting customers with broader choices and improved services.
• **Creditors**: The company's 'going concern' status and default on a note payable indicate elevated credit risk. Significant related-party debt and conversions of debt to equity or notes impact the company's financial structure and repayment capacity.
• **Regulatory Bodies**: The acknowledged ineffectiveness of disclosure controls and internal controls over financial reporting could lead to increased scrutiny and potential regulatory actions from the SEC.

Next Steps

• Seek additional capital of $5 million over the next twelve months through private placement offerings of debt and equity securities.
• Reinvest any future surplus income into growing the company through additional investment.
• Establish an Audit Committee of the Board of Directors, consisting of independent directors, with at least one qualified financial expert.
• Establish a Compensation Committee of the Board of Directors to review and approve salary and benefits policies, including executive compensation.
• Establish a Nominating and Corporate Governance Committee of the Board of Directors to assist in director selection and review corporate governance practices.
• Adopt a formal, written code of conduct.
• Address and remediate deficiencies in disclosure controls and procedures and internal controls over financial reporting, including implementing proper segregation of duties, formal documentation, and multiple levels of supervision and review.
• Continue efforts to diversify the product line and client base to reduce concentration risk.
• Continue to pursue growth in international markets, particularly South Korea and China.
• Monitor and adapt to developments in nuclear power technologies (SMR, MSR, LFTR) and public acceptance of nuclear energy.
• Work with the transfer agent to cancel 834,000 common shares issued in error on March 19, 2025.

Key Dates

Recommendation

Keywords

Nuclear Radiation Detection, Tritium Monitors, SEC Filing, 10-K Annual Report, US Nuclear Corp, UCLE, Radiation Safety Equipment, Molten Salt Reactors, LFTR, CANDU Reactors, Private Placement, Accredited Investor, Corporate Governance, Internal Controls, Going Concern, Financial Performance, Risk Factors, OTC Market